Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Microsoft
MSFT
|
+$277M |
| 2 |
Procter & Gamble
PG
|
+$254M |
| 3 |
Advanced Micro Devices
AMD
|
+$189M |
| 4 |
Analog Devices
ADI
|
+$187M |
| 5 |
Home Depot
HD
|
+$166M |
Top Sells
| 1 |
Tesla
TSLA
|
+$2.36B |
| 2 |
Zoom
ZM
|
+$944M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$779M |
| 4 |
Walmart
WMT
|
+$759M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$591M |
Sector Composition
| 1 | Healthcare | 22.93% |
| 2 | Technology | 16.66% |
| 3 | Consumer Staples | 12.21% |
| 4 | Consumer Discretionary | 9.52% |
| 5 | Communication Services | 9.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
PEI
2826
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $475K | ﹤0.01% |
+57,161
| New | +$475K |
|
|
CCM
2827
Concord Medical Services
CCM
$24.5M
| $471K | ﹤0.01% |
23,830
+140
| +0.6% | +$2.77K |
|
|
SII
2828
Sprott
SII
$1.78B
| $471K | ﹤0.01% |
13,790
-69,900
| -84% | -$2.39M |
|
2829
StoneX
SNEX
$5.02B
| $471K | ﹤0.01% |
20,702
-40,109
| -66% | -$913K |
|
2830
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$68.8M
| $470K | ﹤0.01% |
+7,870
| New | +$470K |
|
2831
Amerant Bancorp
AMTB
$880M
| $469K | ﹤0.01% |
50,403
-24,600
| -33% | -$229K |
|
2832
Vanguard Information Technology ETF
VGT
$103B
| $467K | ﹤0.01% |
1,500
-3,400
| -69% | -$1.06M |
|
|
QNRX
2833
Quoin Pharmaceuticals
QNRX
$4.36M
| $466K | ﹤0.01% |
11
-2
| -15% | -$84.7K |
|
2834
Alaunos Therapeutics
TCRT
$4.83M
| $466K | ﹤0.01% |
1,233
+895
| +265% | +$338K |
|
2835
Daxor
DXR
$56.7M
| $465K | ﹤0.01% |
29,521
+4,000
| +16% | +$63K |
|
|
ODT
2836
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $465K | ﹤0.01% |
+34,600
| New | +$465K |
|
2837
Dorian LPG
LPG
$1.35B
| $464K | ﹤0.01% |
57,964
-153,258
| -73% | -$1.23M |
|
2838
Oragenics
OGEN
$4.75M
| $464K | ﹤0.01% |
448
+309
| +222% | +$320K |
|
|
AUMN
2839
DELISTED
Golden Minerals Company
AUMN
| $464K | ﹤0.01% |
44,192
-26,880
| -38% | -$282K |
|
2840
Paranovus Entertainment Technology
PAVS
$57.2M
| $463K | ﹤0.01% |
13,083
+4,212
| +47% | +$149K |
|
2841
Performance Shipping
PSHG
$23.9M
| $458K | ﹤0.01% |
5,177
+313
| +6% | +$27.7K |
|
|
MDP
2842
DELISTED
Meredith Corporation
MDP
| $457K | ﹤0.01% |
+34,800
| New | +$457K |
|
|
RUHN
2843
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
| $454K | ﹤0.01% |
173,300
-20,100
| -10% | -$52.7K |
|
|
OPOF
2844
DELISTED
Old Point Financial
OPOF
| $452K | ﹤0.01% |
29,835
-6,628
| -18% | -$100K |
|
|
TSRI
2845
DELISTED
TSR Inc. New
TSRI
| $452K | ﹤0.01% |
87,073
+9,423
| +12% | +$48.9K |
|
2846
Avalo Therapeutics
AVTX
$145M
| $451K | ﹤0.01% |
69
-99
| -59% | -$647K |
|
2847
ODP
ODP
$611M
| $451K | ﹤0.01% |
23,192
-142,710
| -86% | -$2.78M |
|
|
SOHO
2848
Sotherly Hotels
SOHO
$16M
| $450K | ﹤0.01% |
250,138
-115,532
| -32% | -$208K |
|
2849
iShares 10-20 Year Treasury Bond ETF
TLH
$11.6B
| $450K | ﹤0.01% |
2,700
-900
| -25% | -$150K |
|
2850
NovaBay Pharmaceuticals
NBY
$17.1M
| $448K | ﹤0.01% |
500
+283
| +130% | +$254K |
|